259 related articles for article (PubMed ID: 10516340)
21. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P; Bagga A; Jindal N; Srivastava RN
Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
[TBL] [Abstract][Full Text] [Related]
22. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
23. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
[TBL] [Abstract][Full Text] [Related]
24. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
25. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
26. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly.
Nagai R; Cattran DC; Pei Y
Clin Nephrol; 1994 Jul; 42(1):18-21. PubMed ID: 7923961
[TBL] [Abstract][Full Text] [Related]
27. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?
Deegens JK; Assmann KJ; Steenbergen EJ; Hilbrands LB; Gerlag PG; Jansen JL; Wetzels JF
Neth J Med; 2005 Nov; 63(10):393-8. PubMed ID: 16301760
[TBL] [Abstract][Full Text] [Related]
29. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
31. [Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors].
Shilov EM; Tareeva IE; Ivanov AA; Lavrova ON; Krasnova TN; Khudova IIu; Miroshnichenko NG; Ratner MIa; Biriukova LS
Ter Arkh; 2000; 72(6):21-5. PubMed ID: 10900643
[TBL] [Abstract][Full Text] [Related]
32. A clinicopathologic study of primary focal segmental glomerulosclerosis in children.
Lanewala A; Mubarak M; Kazi JI; Akhter F; Sher A; Fayyaz A; Bhatti S
Saudi J Kidney Dis Transpl; 2012 May; 23(3):513-20. PubMed ID: 22569437
[TBL] [Abstract][Full Text] [Related]
33. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
Sozeri B; Mir S; Mutlubas F; Sen S
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
[TBL] [Abstract][Full Text] [Related]
34. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.
Tune BM; Kirpekar R; Sibley RK; Reznik VM; Griswold WR; Mendoza SA
Clin Nephrol; 1995 Feb; 43(2):84-8. PubMed ID: 7736683
[TBL] [Abstract][Full Text] [Related]
35. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
36. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
38. Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases.
Mungan S; Turkmen E; Aydin MC; Saglam AE; Baydar DE
Ren Fail; 2015 Jun; 37(5):858-65. PubMed ID: 25857429
[TBL] [Abstract][Full Text] [Related]
39. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[TBL] [Abstract][Full Text] [Related]
40. Treatment with cyclophosphamide in elderly-onset nephrotic syndrome.
Mak SK; Lo KY; Wong CY; Tong GM; Wong PN; Wong AK
Nephron Clin Pract; 2005; 101(1):c25-32. PubMed ID: 15886494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]